Product NDC: | 0024-5840 |
Proprietary Name: | ZALTRAP |
Non Proprietary Name: | ziv-aflibercept |
Active Ingredient(s): | 100 mg/4mL & nbsp; ziv-aflibercept |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0024-5840 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125418 |
Marketing Category: | BLA |
Start Marketing Date: | 20120803 |
Package NDC: | 0024-5840-03 |
Package Description: | 3 VIAL in 1 CARTON (0024-5840-03) > 4 mL in 1 VIAL |
NDC Code | 0024-5840-03 |
Proprietary Name | ZALTRAP |
Package Description | 3 VIAL in 1 CARTON (0024-5840-03) > 4 mL in 1 VIAL |
Product NDC | 0024-5840 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ziv-aflibercept |
Dosage Form Name | SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120803 |
Marketing Category Name | BLA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | ZIV-AFLIBERCEPT |
Strength Number | 100 |
Strength Unit | mg/4mL |
Pharmaceutical Classes |